Perspectives on Quality Attributes of Drug Products Containing Nanomaterials
In this article, the contents of a stimulus article produced by the joint subcommittee of the USP Expert Committees on Dosage Forms, Physical Analysis, and Excipients and relevant comments from a workshop session are summarized.
GMPs for Method Validation in Early Development: An Industry Perspective (Part II)
IQ Consortium representatives explore industry approaches for applying GMPs in early development.